Skip to main content
Clinical Trials/ISRCTN94462049
ISRCTN94462049
Terminated
未知

Deep infiltrating endometriosis: management by medical treatment versus early surgery: DIAMOND

HS Grampian0 sites18 target enrollmentMay 10, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
HS Grampian
Enrollment
18
Status
Terminated
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 10, 2022
End Date
April 30, 2025
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
HS Grampian

Eligibility Criteria

Inclusion Criteria

  • 1\. Women aged 18–49 years old seeking treatment for pain
  • 2\. Laparoscopically confirmed deep endometriosis \+/\- radiological imaging
  • 3\. Suitable for either medical or surgical management
  • 4\. Able and willing to give informed consent to participate and to participate in study procedures

Exclusion Criteria

  • 1\. Unfit for laparoscopic surgery
  • 2\. Have used or currently using GnRH analogues without satisfactory relief of pain symptoms
  • 3\. Previous bilateral oophorectomy
  • 4\. Previous surgery for deep endometriosis
  • 5\. Planning to conceive in the next 18 months
  • 6\. Confirmed bowel stenosis
  • 7\. Hydronephrosis or hydroureter caused by ureteric stenosis
  • 8\. Endometrioma \>5 cm in diameter
  • 9\. Women with preference for medical treatment or surgical treatment
  • 10\. Current pregnancy or breastfeeding

Outcomes

Primary Outcomes

Not specified

Similar Trials